Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX Treatment in Adult Patients with Upper Limb Spasticity
2013-002346-37Phase 3Terminated
- Sponsor
- Allergan
- Start
- May 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in Muscle spasm and upper extremity spasticity (2 arms), sponsored by Allergan. Primary endpoint: Change from baseline in MAS-B elbow flexors. Started May 2014; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
Muscle spasmupper extremity spasticity
Beyond the preview
Go deeper on 2013-002346-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002346-37.